Surgery Partners, Inc.
General ticker "SGRY" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $2.8B (TTM average)
Surgery Partners, Inc. does not follow the US Stock Market performance with the rate: -3.0%.
Estimated limits based on current volatility of 1.3%: low 16.91$, high 17.47$
Factors to consider:
- Total employees count: 15000 (+11.1%) as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Third-party risks, Integration and management of acquired facilities, Pandemic risks, Market competition, Labor/talent shortage/retention
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [14.39$, 26.28$]
- 2025-12-31 to 2026-12-31 estimated range: [13.82$, 25.13$]
Financial Metrics affecting the SGRY estimates:
- Positive: with PPE of 22.1 at the end of fiscal year the price was neutral
- Positive: 7.86 < Operating profit margin, % of 11.20
- Negative: Industry operating cash flow per share per price (median), % of 3.25 <= 5.52
- Positive: Inventory ratio change, % of 0.09 <= 0.84
- Positive: 18.93 < Shareholder equity ratio, % of 22.68 <= 41.86
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: Interest expense per share per price, % of 7.70 > 3.41
- Positive: 6.82 < Operating cash flow per share per price, % of 11.46
Short-term SGRY quotes
Long-term SGRY plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $2,539.30MM | $2,743.30MM | $3,114.30MM |
| Operating Expenses | $2,194.10MM | $2,415.30MM | $2,765.50MM |
| Operating Income | $345.20MM | $328.00MM | $348.80MM |
| Non-Operating Income | $-234.90MM | $-193.00MM | $-201.70MM |
| Interest Expense | $234.90MM | $193.00MM | $201.70MM |
| Income(Loss) | $110.30MM | $135.00MM | $147.10MM |
| Taxes | $23.30MM | $0.30MM | $134.60MM |
| Profit(Loss)* | $-54.60MM | $-11.90MM | $-168.10MM |
| Stockholders Equity | $1,998.20MM | $1,987.20MM | $1,789.70MM |
| Inventory | $71.40MM | $75.20MM | $88.40MM |
| Assets | $6,682.10MM | $6,876.70MM | $7,890.00MM |
| Operating Cash Flow | $158.80MM | $293.80MM | $300.10MM |
| Capital expenditure | $80.60MM | $88.80MM | $90.40MM |
| Investing Cash Flow | $-307.90MM | $-225.60MM | $-488.50MM |
| Financing Cash Flow | $42.10MM | $-155.20MM | $262.00MM |
| Earnings Per Share** | $-0.59 | $-0.09 | $-1.33 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.